Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry project

Abstract Background This study aimed to evaluate the prognostic significance and clinical impact of the revised 2022 European LeukemiaNet (ELN) classification for acute myeloid leukemia (AML), focusing particularly on patients harboring fms-like tyrosine kinase 3-internal tandem duplication (FLT3-IT...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Ibrahim Ethem Pinar, Serhat Celik, Merve Gokcen Polat, Aylin Fatma Karatas, Ali Dogan, Utku Iltar, Guldane Cengiz Seval, Umit Yavuz Malkan, Idris Ince, Emel Merve Yenihayat, Aydan Akdeniz, Murat Kacmaz, Ramazan Erdem, Hacer Berna Afacan Ozturk, Hakki Onur Kirkizlar, Gulten Korkmaz, Fatma Aykas, Ozgur Mehtap, Burak Deveci, Omur Gokmen Sevindik, Ferda Can, Demircan Ozbalci, Hale Bulbul, Salih Sertac Durusoy, Unal Atas, Muzaffer Keklik, Selami Kocak Toprak, Hakan Goker, Fatih Demirkan, Fahir Ozkalemkas, Inci Alacacioglu, Volkan Karakus, the Turkish Society of Hematology-Acute Leukemias Working Group
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2025-10-01
Serija:	BMC Cancer
Teme:	Acute myeloid leukemia European LeukemiaNet FLT3-ITD mutation Risk stratification Prognostic value
Online dostop:	https://doi.org/10.1186/s12885-025-14987-z
Oznake:	Označite Brez oznak, prvi označite!